Bone Biologics Corporation (BBLG) Operating cash flow 2016–2025
Bone Biologics Corporation (BBLG) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$2.7MFY2025 · since FY2016: -$7.3M → -$2.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$2.7M | +34.8% |
| FY2024 | -$4.1M | +56.8% |
| FY2023 | -$9.6M | -167.9% |
| FY2022 | -$3.6M | -190.3% |
| FY2021 | -$1.2M | -187.8% |
| FY2020 | -$426,933 | +86.9% |
| FY2019 | -$3.3M | +20.8% |
| FY2018 | -$4.1M | -23.3% |
| FY2017 | -$3.3M | +54.6% |
| FY2016 | -$7.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BBLG financial trends
BBLG RevenueBBLG Net incomeBBLG Net marginBBLG Gross profitBBLG Gross marginBBLG Operating incomeBBLG Operating marginBBLG Free cash flowBBLG Capital expendituresBBLG Return on equityBBLG Stock buybacksBBLG Dividends paidBBLG Total assetsBBLG Total liabilitiesBBLG Shareholders’ equityBBLG overview →